These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 33749761)

  • 41. Prevalence of monoclonal gammopathy of undetermined significance in Asia: a viewpoint from nagasaki atomic bomb survivors.
    Iwanaga M; Tomonaga M
    Clin Lymphoma Myeloma Leuk; 2014 Feb; 14(1):18-20. PubMed ID: 24461807
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Computational Model of Progression to Multiple Myeloma Identifies Optimum Screening Strategies.
    Altrock PM; Ferlic J; Galla T; Tomasson MH; Michor F
    JCO Clin Cancer Inform; 2018 Dec; 2():1-12. PubMed ID: 30652561
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic Biomarkers in the Progression From MGUS to Multiple Myeloma: A Systematic Review.
    Cosemans C; Oben B; Arijs I; Daniëls A; Declercq J; Vanhees K; Froyen G; Maes B; Mebis J; Rummens JL
    Clin Lymphoma Myeloma Leuk; 2018 Apr; 18(4):235-248. PubMed ID: 29506935
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Monoclonal gammopathy of uncertain significance (MGUS) and ionizing radiation].
    Taino G; Buonocore C; Stanga A; Imbriani M
    G Ital Med Lav Ergon; 2020 Dec; 42(4):292-297. PubMed ID: 33600657
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic value of circulating plasma cells in monoclonal gammopathy of undetermined significance.
    Kumar S; Rajkumar SV; Kyle RA; Lacy MQ; Dispenzieri A; Fonseca R; Lust JA; Gertz MA; Greipp PR; Witzig TE
    J Clin Oncol; 2005 Aug; 23(24):5668-74. PubMed ID: 16110026
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression.
    Kyle RA; Rajkumar SV
    Br J Haematol; 2007 Dec; 139(5):730-43. PubMed ID: 18021088
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study.
    Landgren O; Kyle RA; Pfeiffer RM; Katzmann JA; Caporaso NE; Hayes RB; Dispenzieri A; Kumar S; Clark RJ; Baris D; Hoover R; Rajkumar SV
    Blood; 2009 May; 113(22):5412-7. PubMed ID: 19179464
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased prevalence of light chain monoclonal gammopathy of undetermined significance (LC-MGUS) in first-degree relatives of individuals with multiple myeloma.
    Greenberg AJ; Rajkumar SV; Larson DR; Dispenzieri A; Therneau TM; Colby CL; Phelps TK; Kumar SK; Katzmann JA; Kyle RA; Slager SL; Vachon CM
    Br J Haematol; 2012 May; 157(4):472-5. PubMed ID: 22629552
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predictive Immune Markers for Disease Progression in Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance.
    İşgör İŞ; Toptaş T; Türkoz HK
    Turk J Haematol; 2022 Dec; 39(4):245-253. PubMed ID: 35965418
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification and monitoring of Copy Number Variants (CNV) in monoclonal gammopathy.
    Sallustio F; Curci C; Solimando AG; Leone P; Pontrelli P; Gesualdo L; Vacca A; Racanelli V; Gallone A
    Cancer Biol Ther; 2021 Jun; 22(5-6):404-412. PubMed ID: 34288806
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognosis of young patients with monoclonal gammopathy of undetermined significance (MGUS).
    Pang L; Rajkumar SV; Kapoor P; Buadi F; Dispenzieri A; Gertz M; Lacy M; Kyle R; Kumar S
    Blood Cancer J; 2021 Feb; 11(2):26. PubMed ID: 33563898
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bone-marrow immunophenotypic analysis allows the identification of high risk of progression and immune condition-related monoclonal gammopathy of undetermined significance.
    Jerez A; Ortuño FJ; Osma Mdel M; Español I; González AD; Roldán V; de Arriba F; Vicente V
    Ann Med; 2009; 41(7):547-58. PubMed ID: 19634064
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identifying monoclonal gammopathy of undetermined significance from electronic health records.
    Tanenbaum HC; Birmann BM; Bertrand KA; Teras LR; Krishnan AY; Pourhassan H; Goldsmith S; Cannavale K; Wang SS; Chao CR
    Cancer Rep (Hoboken); 2023 Mar; 6(3):e1755. PubMed ID: 36464325
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of optimal follow-up of monoclonal gammopathy of undetermined significance on early diagnosis and prevention of myeloma-related complications.
    Bianchi G; Kyle RA; Colby CL; Larson DR; Kumar S; Katzmann JA; Dispenzieri A; Therneau TM; Cerhan JR; Melton LJ; Rajkumar SV
    Blood; 2010 Sep; 116(12):2019-25; quiz 2197. PubMed ID: 20495076
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MGUS and smoldering myeloma: the most prevalent of plasma cell dyscrasias.
    Richardson PG; Laubach J; Mitsiades CS; Schlossman RL; Ghobrial IM; Munshi NC; Anderson KC
    Oncology (Williston Park); 2011 Jun; 25(7):594, 596. PubMed ID: 21888257
    [No Abstract]   [Full Text] [Related]  

  • 56. Monoclonal gammopathy of undeterminated significance: introduction and current clinical issues.
    Klincová M; Sandecká V; Mikuláiová A; Radocha J; Maisnar V; Hájek R
    Klin Onkol; 2011; 24 Suppl():S14-7. PubMed ID: 21923058
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Monoclonal gammopathy of undetermined significance, multiple myeloma, and osteoporosis.
    Bouvard B; Royer M; Chappard D; Audran M; Hoppé E; Legrand E
    Joint Bone Spine; 2010 Mar; 77(2):120-4. PubMed ID: 20097594
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quantifiable excess of bone resorption in monoclonal gammopathy is an early symptom of malignancy: a prospective study of 87 bone biopsies.
    Bataille R; Chappard D; Basle MF
    Blood; 1996 Jun; 87(11):4762-9. PubMed ID: 8639847
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Monoclonal Gammopathy of Undetermined Significance After Kidney Transplantation: Single-Center Experience.
    Alfano G; Fontana F; Colaci E; Messerotti A; Bettelli F; Potenza L; Luppi M; Cappelli G
    Transplantation; 2017 Nov; 101(11):e337-e342. PubMed ID: 28731904
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Monoclonal gammopathy of undetermined significance].
    Hermansen NEU; Silkjær T; Hansen CT; Aagaard TG; Gregersen H
    Ugeskr Laeger; 2020 Mar; 182(10):. PubMed ID: 32138824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.